Pomdoctor holds extraordinary shareholder meeting on ADR program termination proposal

• Pomdoctor held an extraordinary shareholder meeting on Sept. 30, 2026.
• Shareholders backed a non-binding advisory resolution endorsing termination of the ADR program and a direct Nasdaq listing of Class A shares.
• Execution was not confirmed; the plan contemplates the ADR termination and direct listing occurring on the same date.
• An ordinary resolution authorizing a 10-for-1 share consolidation was adopted.
• The consolidation is slated to take effect simultaneously with the ADR termination and direct listing; implementation was not confirmed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-106373), on October 02, 2026, and is solely responsible for the information contained therein.